CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early-Stage trial tests new pill for untreated blood cancer
Disease control TerminatedThis study tested an investigational oral drug called umbralisib in patients with chronic lymphocytic leukemia (CLL) who had never received treatment before. The goal was to see how well the drug worked to control the cancer and how safe it was for patients. The trial was small a…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
First human test of experimental cancer drug halted
Disease control TerminatedThis was an early-stage study to test the safety and find the right dose of a new drug called JBH492. It involved 25 patients whose chronic lymphocytic leukemia or non-Hodgkin's lymphoma had returned or did not respond to previous treatments. The main goal was to see how much of …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Cancer center tests combo therapy for aggressive blood cancer
Disease control TerminatedThis study tested whether combining two drugs (ibrutinib and pembrolizumab) could improve immune function and control chronic lymphocytic leukemia in high-risk patients who hadn't received prior treatment. The trial was designed to measure how well patients responded to the treat…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Terminated trial tests new combo for tough blood cancers
Disease control TerminatedThis early-phase study aimed to see if combining two targeted drugs, tafasitamab and parsaclisib, was safe and effective for adults whose non-Hodgkin lymphoma or chronic lymphocytic leukemia had returned or stopped responding to prior treatments. The trial enrolled 54 participant…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Two-Punch combo aims to wipe out leukemia, offering hope for treatment breaks
Disease control TerminatedThis trial tested a two-drug combination (ibrutinib and venetoclax) for adults with chronic lymphocytic leukemia (CLL) that had returned or stopped responding to prior treatment. The goal was to see if using the drugs together could achieve a deep remission, potentially allowing …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: Swiss Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New drug combo aims to wipe out lingering blood cancer cells
Disease control TerminatedThis study tested if adding a new drug called pirtobrutinib to an existing treatment (venetoclax) could help eliminate the last traces of cancer in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. It was for adults who had already been on venetoclax for a…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC